|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,351.90 INR | +1.05% |
|
+2.58% | +11.36% |
| Jun. 17 | Lupin Limited Launches Azilsartan Medoxomil Tablets in the United States | CI |
| Jun. 08 | Lupin Teams Up with Laboratorios ERN for Asthma, COPD Drug Launch in Spain | MT |
| Market Cap | 1,075B 11.4B 9.94B 9.2B 8.61B 16.16B 16.25B 109B 42.31B 529B 42.78B 41.86B 1,838B | P/E 2026 |
19.9x | P/E 2027 * | 23.4x |
|---|---|---|---|---|---|
| Enterprise Value | 1,062B 11.26B 9.81B 9.09B 8.51B 15.96B 16.05B 108B 41.79B 523B 42.25B 41.35B 1,815B | EV / Sales 2026 |
3.69x | EV / Sales 2027 * | 3.48x |
| Free-Float |
52.97% | Yield 2026 |
0.78% | Yield 2027 * | 0.55% |
Last Transcript: Lupin Limited
| 1 day | +1.05% | ||
| 1 week | +2.58% | ||
| Current month | +3.50% | ||
| 1 month | +2.86% | ||
| 3 months | +4.35% | ||
| 6 months | +10.64% | ||
| Current year | +11.36% |
| 1 week | 2,253.9 |  | 2,355.5 |
| 1 month | 2,219.8 | | 2,355.5 |
| Current year | 2,072.95 | | 2,492 |
| 1 year | 1,838.65 | | 2,492 |
| 3 years | 829.25 | | 2,492 |
| 5 years | 583.05 | | 2,492 |
| 10 years | 505 | | 2,492 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 2013-08-31 | |
| Director of Finance/CFO | 61 | 2007-08-12 | |
Amit Kumar Gupta
CMP | Compliance Officer | - | 2024-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 52 | 2008-10-07 | |
| Director/Board Member | 58 | 1996-12-31 | |
| Chairman | 82 | 2017-08-10 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.05% | +2.58% | +21.70% | +185.03% | 11.4B | |
| -1.21% | -3.04% | +39.94% | +145.38% | 980B | |
| -2.48% | -5.18% | +51.52% | +39.07% | 550B | |
| -2.14% | -4.94% | +16.71% | +56.15% | 382B | |
| +0.25% | -3.09% | +23.00% | +15.81% | 316B | |
| +0.61% | -1.69% | +25.42% | +13.64% | 272B | |
| +0.22% | -3.10% | +24.25% | +30.21% | 268B | |
| +4.59% | +1.98% | -40.02% | -45.89% | 199B | |
| -1.19% | -4.95% | +16.56% | +47.00% | 182B | |
| -1.35% | -1.46% | +14.59% | +56.94% | 154B | |
| Average | -0.16% | -2.46% | +19.37% | +54.33% | 331.37B | |
| Weighted average by Cap. | -0.77% | -3.65% | +27.78% | +64.11% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 272B 2.88B 2.51B 2.32B 2.18B 4.08B 4.11B 27.58B 10.69B 134B 10.81B 10.57B 464B | 296B 3.14B 2.74B 2.54B 2.38B 4.45B 4.48B 30.1B 11.67B 146B 11.79B 11.54B 507B |
| Net income | 49.02B 519M 453M 420M 393M 736M 741M 4.98B 1.93B 24.13B 1.95B 1.91B 83.78B | 45.98B 487M 425M 394M 368M 691M 695M 4.67B 1.81B 22.63B 1.83B 1.79B 78.59B |
| Net Debt | -13.22B -140M -122M -113M -106M -199M -200M -1.34B -520M -6.51B -526M -515M -22.6B | -42.53B -451M -393M -364M -341M -639M -643M -4.32B -1.67B -20.94B -1.69B -1.66B -72.7B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-19 | 2,351.90 ₹ | +1.05% | 82,209 |
| 26-06-18 | 2,327.50 ₹ | +2.68% | 21,808 |
| 26-06-17 | 2,266.80 ₹ | -0.45% | 44,751 |
| 26-06-16 | 2,277.00 ₹ | +0.15% | 12,983 |
| 26-06-15 | 2,273.50 ₹ | -0.84% | 281,296 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LUPIN Stock
Select your edition
All financial news and data tailored to specific country editions
